RTW INVESTMENTS LP 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 07:35 am Sale | 2023-12-31 | 13G | C4 Therapeutics, Inc. CCCC | RTW INVESTMENTS LP | 0 0.000% | -2,819,472![]() (Position Closed) | Filing |
2023-02-14 10:08 am Purchase | 2022-12-31 | 13G | C4 Therapeutics, Inc. CCCC | RTW INVESTMENTS LP | 2,819,472 5.800% | 324,507![]() (+13.01%) | Filing |
2022-02-14 09:31 am Purchase | 2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC | RTW INVESTMENTS LP | 2,494,965 5.100% | 2,494,965![]() (New Position) | Filing |